Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024 0

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024 0

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024 16

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024 16

What happens when a kneecap dislocates

by Mayo Clinic News Network, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainKnee dislocation can be caused by a sudden blow, such as taking a hard hit playing a contact sport like football o

Updated on: March 09,2024 15

What happens when a kneecap dislocates

by Mayo Clinic News Network, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainKnee dislocation can be caused by a sudden blow, such as taking a hard hit playing a contact sport like football o

Updated on:March 09,2024 15

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on: January 21,2024 11

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on:January 21,2024 11

Researchers identify feature of early stage colorectal cancer tumors that signals aggressiveness

by Cheryl Critchley,Monash UniversityOncogenic KRAS-driven MAPK signaling confers tolerance to epithelial TGFβ activation. a Representative H&E and Alk5 ISH of small intestinal tissue from V

Updated on: February 20,2024 19

Researchers identify feature of early stage colorectal cancer tumors that signals aggressiveness

by Cheryl Critchley,Monash UniversityOncogenic KRAS-driven MAPK signaling confers tolerance to epithelial TGFβ activation. a Representative H&E and Alk5 ISH of small intestinal tissue from V

Updated on:February 20,2024 19

Liver cancer deaths climb by around 50% in the last decade

by Cancer Research UKA graph showing liver cancer mortality. Credit: Cancer Research UKLiver cancer deaths have increased by around 50% in the last decade and have tripled since records began, ac

Updated on: April 23,2024 15

Liver cancer deaths climb by around 50% in the last decade

by Cancer Research UKA graph showing liver cancer mortality. Credit: Cancer Research UKLiver cancer deaths have increased by around 50% in the last decade and have tripled since records began, ac

Updated on:April 23,2024 15

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on: June 01,2024 8

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on:June 01,2024 8

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on: April 02,2024 13

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on:April 02,2024 13

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3

Updated on: January 28,2024 12

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3

Updated on:January 28,2024 12

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on: May 06,2024 14

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on:May 06,2024 14

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on: June 11,2024 7

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on:June 11,2024 7

Researchers identify a better biomarker for an aggressive and fatal liver cancer

by Ryn Thorn,Medical University of South CarolinaDr. Anand Mehta (left) and Dr. Shaaron Ochoa-Rios (right) in the Mehta laboratory at the Medical University of South Carolina. Credit: Medical Un

Updated on: February 18,2024 11

Researchers identify a better biomarker for an aggressive and fatal liver cancer

by Ryn Thorn,Medical University of South CarolinaDr. Anand Mehta (left) and Dr. Shaaron Ochoa-Rios (right) in the Mehta laboratory at the Medical University of South Carolina. Credit: Medical Un

Updated on:February 18,2024 11